Company intelligence / Profile preview

Addison-Davis Diagnostics

Greenwich, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Addison-Davis Diagnostics was a medical technology company specializing in the development and manufacture of rapid diagnostic tests. The company is best known for pioneering the first rapid Strep A test, which significantly improved the speed of diagnosing streptococcal pharyngitis in clinical settings. Their product portfolio also included rapid pregnancy tests (hCG) and other point-of-care diagnostic solutions. In 1994, the company was acquired by Quidel Corporation, a leader in the diagnostic industry, to expand Quidel's presence in the rapid testing market.

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: DeviceRapid immunoassay
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Addison-Davis Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Addison-Davis Diagnostics.

Explore the full profile